X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (189) 189
index medicus (174) 174
physics (174) 174
high energy physics - experiment (173) 173
humans (172) 172
physical sciences (166) 166
natural sciences (165) 165
naturvetenskap (165) 165
fysik (164) 164
particle physics (159) 159
physics, particles & fields (136) 136
female (123) 123
physics - high energy physics - experiment (116) 116
high energy physics (110) 110
physics of elementary particles and fields (109) 109
middle aged (89) 89
nuclear experiment (88) 88
male (87) 87
adult (79) 79
aged (75) 75
subatomic physics (66) 66
subatomär fysik (66) 66
oncology (60) 60
phenomenology (57) 57
analysis (56) 56
collisions (55) 55
hep (53) 53
elementary particles, quantum field theory (52) 52
quantum field theories, string theory (52) 52
物理学 (50) 50
astronomy & astrophysics (48) 48
breast cancer (47) 47
cern lhc coll (47) 47
detectors (45) 45
nuclear physics (45) 45
research (45) 45
ex (43) 43
care and treatment (41) 41
hadron-hadron scattering (41) 41
large hadron collider (41) 41
astronomy, astrophysics and cosmology (40) 40
cancer (39) 39
parton distributions (39) 39
physics, nuclear (37) 37
animals (36) 36
experimental results (36) 36
measurement science and instrumentation (34) 34
nuclear energy (34) 34
nuclear physics, heavy ions, hadrons (34) 34
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (32) 32
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (32) 32
aged, 80 and over (32) 32
infectious diseases (31) 31
treatment outcome (31) 31
health aspects (30) 30
medicine (30) 30
risk factors (30) 30
nucl (29) 29
research article (29) 29
diagnosis (28) 28
multidisciplinary sciences (28) 28
transverse momentum (28) 28
management (27) 27
microbiology (27) 27
mortality (27) 27
breast neoplasms - drug therapy (26) 26
survival (26) 26
breast neoplasms - pathology (25) 25
model (25) 25
astrophysics (24) 24
decay (24) 24
prognosis (24) 24
science (24) 24
young adult (24) 24
nuclear and high energy physics (23) 23
scattering [p p] (23) 23
medicine & public health (22) 22
particle physics - experiment (22) 22
prospective studies (22) 22
therapy (22) 22
chemotherapy (21) 21
lhc (21) 21
metastasis (21) 21
spain (21) 21
luminosity (20) 20
proteins (20) 20
regular - experimental physics (20) 20
standard model (20) 20
epidemiology (19) 19
science & technology (19) 19
abridged index medicus (18) 18
classical and quantum gravitation, relativity theory (18) 18
drug therapy (18) 18
high energy astrophysical phenomena (18) 18
p p: scattering (18) 18
particle collisions (18) 18
physics and astronomy (18) 18
physics, multidisciplinary (18) 18
prevalence (18) 18
quantum physics (18) 18
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 904 - 916
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast... 
Hematology, Oncology and Palliative Medicine | HETEROGENEITY | WOMEN | PALBOCICLIB | THERAPY | EXEMESTANE | ONCOLOGY | MUTATION | RESISTANCE | COMBINATION | AROMATASE INHIBITORS | PI3K INHIBITOR | Estradiol - analogs & derivatives | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Receptors, Estrogen - analysis | Fulvestrant | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Hyperglycemia - chemically induced | DNA, Neoplasm - blood | DNA Mutational Analysis | Exanthema - chemically induced | Postmenopause | Female | Morpholines - adverse effects | Aminopyridines - administration & dosage | Drug Eruptions - etiology | Double-Blind Method | Morpholines - administration & dosage | Estradiol - administration & dosage | Survival Rate | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Retreatment | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Aspartate Aminotransferases - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Medical colleges | Clinical trials | Product development | Breast cancer | Postmenopausal women | Hormones | Antineoplastic agents | Analysis
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 914 - 923
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 461 - 471
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 545 - 554
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1269 - 1278
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 6, pp. 798 - 805.e2
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 24, pp. 2527 - 2538
Abstract Objectives The aim of this study was to describe the incidence, mechanisms, features, and management of aseptic intracardiac shunts (AICS). Background... 
Cardiovascular | cardiac shunts | TAVR | percutaneous closure devices
Journal Article
Journal Article